Skip to main content
OpenTrials

Clinical trial condition

Human Epidermal Growth Factor 2 Positive Carcinoma of Breast

Explore clinical trials studying Human Epidermal Growth Factor 2 Positive Carcinoma of Breast. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Human Epidermal Growth Factor 2 Positive Carcinoma of Breast trial results

Active, Not Recruiting

Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib

NCT05323955

Conditions
Advanced Breast Cancer, Brain Diseases, Brain Metastases, +8 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
  • Washington University in St. Louis St Louis, Missouri, United States
View Trial Details

Related conditions